IBBIS (International Biosecurity and Biosafety Initiative for Science)

Active Grant Applications

• AppliedScaling adoption of synthesis screening outside the US and EU→grantmaking.ai· grantmaking.ai Launch Round· Applied Jul 13, 2026· $25,000 (up to $100,000)
  What this application is for

  What this project is

  This is a critical time for adoption of effective synthesis screening tools. New mandates for enhanced screening under the US framework come online in October 2026; California AB1864, if it passes, will introduce new requirements in January 2027; and the EU Biotech Act will also likely introduce screening requirements in early 2027. This funding will help IBBIS to accelerate adoption of screening in medium-to-large businesses based in international markets that sell to the US and EU, that other screening tools have limited access to (e.g. in China, India, South Korea and Brazil). This is because compared to other tools, IBBIS maintains a free, open-source screening tool, resources for customer screening, and has already established connections to key organisations and individuals based in these countries, as well as other tool providers such as SecureDNA and IBBIS. Our tool is already in use by providers in China, the US, and EU, but building on the momentum from recent software performance updates, IBBIS is ready for a larger outreach campaign to accelerate adoption during this regulatory window.